Clinical Trial Update: Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is exploring fecal microbiota transplantation for alcohol-related liver disease and cirrhosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol-related Liver Disease
• Cirrhosis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Liver Disease; Alcohol-Related, Cirrhosis | Phase 1, Phase 2 | Status: RECRUITING